JASVINDER SINGH to Janus Kinase Inhibitors
This is a "connection" page, showing publications JASVINDER SINGH has written about Janus Kinase Inhibitors.
Connection Strength
3.000
-
How to Use Janus Kinase Inhibitors in the Treatment of Rheumatoid Arthritis? A Clinical Assessment of Risks and Benefits. Curr Rheumatol Rep. 2023 12; 25(12):295-306.
Score: 0.834
-
The Emerging Safety Profile of JAK Inhibitors in Rheumatic Diseases. BioDrugs. 2023 Sep; 37(5):625-635.
Score: 0.807
-
Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis - Past, Present, and Future. N Engl J Med. 2022 01 27; 386(4):387-389.
Score: 0.732
-
Tapering Janus kinase inhibitors in rheumatoid arthritis with low disease activity or remission: reality or dream? Ann Rheum Dis. 2019 02; 78(2):153-154.
Score: 0.583
-
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021 07; 73(7):1108-1123.
Score: 0.044